USC Stem Cell scientists are advancing our understanding of cancers of the breast, lung, prostate, blood, colon, skin, pancreas, liver, brain, ovaries and eye. They are also using stem cells to find new drugs and regenerative therapies for patients.


  • Approximately 39.6% of men and women will be diagnosed with cancer at some point during their lifetimes.
  • Cancer is among the leading causes of death worldwide.
  • Metastasis is the leading cause of cancer-related death.
  • The most common cancers are projected to be breast, lung and bronchus, prostate, colon and rectum, bladder, melanoma of the skin, non-Hodgkin lymphoma, thyroid cancer, kidney and renal pelvis, leukemia, endometrial and pancreatic.




What is the USC Ombuds?

Stress levels are running high with a pandemic, global recession, and social injustice threatening livelihoods and lives. While the USC Office of the Ombuds can’t resolve the world’s woes, it can serve as a confidential, impartial, informal, and independent problem-solving resource for students, faculty and staff. The University Ombuds—Thomas Kosakowski at the Health Sciences Campus, …

Alec Fisher

Amid COVID-19 fears, USC Spirit Leader donates stem cells for leukemia patient

When Alec Fisher signed up as a potential bone marrow donor two years ago, he didn’t expect to hear back for a while, if at all — and certainly not in the middle of a pandemic. As someone who has had personal experiences with serious health issues, Fisher felt a calling to donate. When he …

Qi-Long Ying

Shanghai Cell Therapy Group launches collaboration with USC researcher to improve the ex vivo expansion of hematopoietic stem cells for clinical applications

Shanghai Cell Therapy Group (SHCell) recently entered into a six-year research collaborative project with Professor Qi-Long Ying from the University of Southern California (USC). Through the project, sponsored by $3.6 million from the Baize Plan Fund, the Ying laboratory aims to develop conditions for the long-term ex vivo expansion of mouse and human hematopoietic stem …

All Cancer News


Min Yu is capturing circulating tumor cells from the bloodstreams of breast cancer patients, and growing and studying them in the laboratory. This enables her lab to gain new insights into cancer and to work towards developing less invasive biopsies and more effective treatments for patients.
All Cancer Videos

Stay connected.